Vision & Goals of the CINP Psychedelics Pharmacology Global Networking Community ​

The Psychedelics Pharmacology GNC is focused on advances in psychedelic research both at clinical and preclinical/mechanistic level, while also considering compounds with psychedelic-like therapeutic potential that do not traditionally belong to the classical psychedelic class (e.g., ketamine and MDMA).

The group aims to promote awareness of the pharmacological properties of psychedelic substances for the treatment of mental and psychiatric disorders and fosters a conceptual framework integrating innovation with experimental evidence.

The main goals are as follows:

• To actively participate to the CINP annual meeting in dedicated sessions
• To plan regular webinars to disseminate most recent advances in psychedelic research
• To support the definition of guidelines for clinical trials using psychedelics
• To deepen the knowledge about molecular and cellular mechanisms of psychedelics
• To engage neuropsychopharmacologists in the discussion on the potential and risks of the therapeutic use of psychedelics